Abuse-Deterrent Opioids: Where Are They Now?

The potential blockbuster category for abuse-deterrent opioids has fizzled. A few stalwarts are pushing on, but the return on investment for many drug manufacturers has been disappointing. Scrip tracked how opioids approved in the last eight years have performed.

Dollar bills
Sales of abuse-deterrent opioids have not lived up to expectations.

More from Drug Pricing

More from Scrip